295 related articles for article (PubMed ID: 26774152)
1. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites.
Lu C; Li L; Luo Z; Cui Y; Fu P; Zhou J; Ma N; Zhou Y
Neoplasma; 2016; 63(2):299-303. PubMed ID: 26774152
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients with Malignant Ascites Secondary to Unresectable Gastric Cancer.
Ba MC; Long H; Zhang XL; Gong YF; Tang YQ; Wu YB; Yu FH; Cui SZ
J Laparoendosc Adv Surg Tech A; 2016 Jan; 26(1):32-9. PubMed ID: 26779722
[TBL] [Abstract][Full Text] [Related]
3. [A pilot study of chemotherapy combined with intraperitoneal perfusion of cytokine-induced killer cells for advanced gastric cancer patients with ascites].
Wang ZM; Zhuang RY; Chen Y; Feng Y; Li Q; Liu TS
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):28-31. PubMed ID: 23355235
[TBL] [Abstract][Full Text] [Related]
4. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
Huang O; Lu X; Xu X; Shi Y
Cell Biochem Biophys; 2015 Mar; 71(2):1171-80. PubMed ID: 25398590
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites.
Randle RW; Swett KR; Swords DS; Shen P; Stewart JH; Levine EA; Votanopoulos KI
Ann Surg Oncol; 2014 May; 21(5):1474-9. PubMed ID: 23982251
[TBL] [Abstract][Full Text] [Related]
6. [Effects of laparoscopic hyperthermic intraperitoneal perfusion chemotherapy combined with intraperitoneal and systemic chemotherapy treatment in patients with untreated gastric cancer with peritoneal metastasis].
Li S; Xue K; Dai HM; Wang YK; Shan F; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):442-447. PubMed ID: 37217352
[No Abstract] [Full Text] [Related]
7. [Postoperative intraperitioneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patients].
Zuo Y; Xu M; Shen D; Lu WD; Lu JF
Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):247-9. PubMed ID: 15312391
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients With Malignant Ascites Secondary to Unresectable Gastric Cancer.
Ba MC; Long H; Zhang XL; Gong YF; Tang YQ; Wu YB; Yu FH; Cui SZ
Surg Laparosc Endosc Percutan Tech; 2020 Feb; 30(1):55-61. PubMed ID: 32004214
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
Yang XJ; Li Y; Yonemura Y
J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
[TBL] [Abstract][Full Text] [Related]
12. B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites.
Cui S; Ba M; Tang Y; Liu J; Wu Y; Wang B; Zhang X; Tang H; Zhong S
Oncol Rep; 2012 Oct; 28(4):1325-31. PubMed ID: 22797826
[TBL] [Abstract][Full Text] [Related]
13. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: results of a single-centre retrospective study.
Yarema RR; Ohorchak MA; Zubarev GP; Mylyan YP; Oliynyk YY; Zubarev MG; Gyrya PI; Kovalchuk YJ; Safiyan VI; Fetsych TG
Int J Hyperthermia; 2014 May; 30(3):159-65. PubMed ID: 24641798
[TBL] [Abstract][Full Text] [Related]
15. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
16. Port-Site Metastases and Chimney Effect of B-Ultrasound-Guided and Laparoscopically-Assisted Hyperthermic Intraperitoneal Perfusion Chemotherapy.
Ba MC; Long H; Zhang XL; Gong YF; Yan ZF; Wang S; Tang YQ; Cui SZ
Yonsei Med J; 2017 May; 58(3):497-504. PubMed ID: 28332353
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
18. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
[TBL] [Abstract][Full Text] [Related]
19. [Laparoscopic intraperitoneal antiblastic hyperthermic chemoperfusion in the treatment of refractory neoplastic ascites. Preliminary results].
Valle M; Garofalo A; Federici O; Cavaliere F
Suppl Tumori; 2005; 4(3):S122-3. PubMed ID: 16437944
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites.
Ba MC; Cui SZ; Lin SQ; Tang YQ; Wu YB; Wang B; Zhang XL
World J Gastroenterol; 2010 Apr; 16(15):1901-7. PubMed ID: 20397270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
